Heat shock factor 1 in protein homeostasis and oncogenic signal integration.

Heat shock factor 1 (HSF1) is a stress-inducible transcription factor and has been described as a multi-faceted modulator of tumorigenesis. Heat shock, accumulation of misfolded proteins, or malignant transformation promotes the activation and nuclear translocation of HSF1, where it binds to the promoters of heat shock proteins and an array of nonheat shock-regulated proteins to upregulate their transcription. These stress-responsive and tumor-promoting genes in turn alter the ability of tumor cells to respond to a variety of stresses and enable them to thrive in less than favorable growth conditions. Although a direct role for HSF1 in promoting mRNA transcription of tumor-promoting genes has been suggested, it appears that this property is context- and cell-type dependent. Furthermore, recent studies have demonstrated a direct involvement of mTOR signaling in regulating HSF1-mediated transcription, thus establishing a direct link between protein translation and HSF1 activity. Interestingly, there is a growing understanding of the signaling pathways that are modulated by HSF1 in a variety of tumor types and the co-option of these survival pathways by HSF1 to promote tumorigenesis. This review will focus on the role of HSF1 in protein homeostasis and HSF1-mediated oncogenic signaling pathways that together promote tumorigenesis.

[1]  S. Calderwood,et al.  HSF1 REGULATION OF β-CATENIN IN MAMMARY CANCER CELLS THROUGH CONTROL OF HUR / ELAVL1 EXPRESSION , 2014, Oncogene.

[2]  K. Kalland,et al.  High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors , 2014, British Journal of Cancer.

[3]  Marc L. Mendillo,et al.  The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy , 2014, Cell.

[4]  N. Marchenko,et al.  A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress , 2014, Cell Death and Disease.

[5]  D. Proia,et al.  mTOR Inhibition Potentiates HSP90 Inhibitor Activity via Cessation of HSP Synthesis , 2014, Molecular Cancer Research.

[6]  J. Rüschoff,et al.  HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer , 2014, Cell Death and Disease.

[7]  Aravind Subramanian,et al.  Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State , 2013, Science.

[8]  W. Linehan,et al.  Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. , 2013, Cancer cell.

[9]  H. Einsele,et al.  The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma , 2013, British journal of haematology.

[10]  Katharine H. Wrighton.  Protein degradation: Ensuring quality at the ribosome , 2012, Nature Reviews Molecular Cell Biology.

[11]  Adam Frost,et al.  A Ribosome-Bound Quality Control Complex Triggers Degradation of Nascent Peptides and Signals Translation Stress , 2012, Cell.

[12]  S. Lindquist,et al.  Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. , 2012, The Journal of clinical investigation.

[13]  Hsiu-Fang Lee,et al.  HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells. , 2012, Cancer research.

[14]  Marc L. Mendillo,et al.  HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers , 2012, Cell.

[15]  D. Moskophidis,et al.  Heat Shock Factor Hsf1 Cooperates with ErbB2 (Her2/Neu) Protein to Promote Mammary Tumorigenesis and Metastasis* , 2012, The Journal of Biological Chemistry.

[16]  S. Calderwood,et al.  mTOR Is Essential for the Proteotoxic Stress Response, HSF1 Activation and Heat Shock Protein Synthesis , 2012, PloS one.

[17]  Qiuyun Liu,et al.  SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells. , 2012, Cancer letters.

[18]  Benjamin J. Raphael,et al.  The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2012, Nature.

[19]  L. Neckers,et al.  Post-translational modifications of Hsp90 and their contributions to chaperone regulation. , 2012, Biochimica et biophysica acta.

[20]  I. Benjamin,et al.  Heat Shock Transcription Factor Hsf1 Is Involved in Tumor Progression via Regulation of Hypoxia-Inducible Factor 1 and RNA-Binding Protein HuR , 2012, Molecular and Cellular Biology.

[21]  Paul Workman,et al.  Hsp90 Molecular Chaperone Inhibitors: Are We There Yet? , 2012, Clinical Cancer Research.

[22]  Marc L. Mendillo,et al.  High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer , 2011, Proceedings of the National Academy of Sciences.

[23]  Andreas Bracher,et al.  Molecular chaperones in protein folding and proteostasis , 2011, Nature.

[24]  F. Talos,et al.  Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells , 2011, Molecular Cancer Research.

[25]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[26]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[27]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[28]  S. Lindquist,et al.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights , 2010, Nature Reviews Molecular Cell Biology.

[29]  M Tan,et al.  Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth , 2009, Oncogene.

[30]  Ji Luo,et al.  Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.

[31]  M. Moasser.  The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis , 2007, Oncogene.

[32]  S. Lindquist,et al.  Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis , 2007, Cell.

[33]  T. Yao,et al.  HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. , 2007, Genes & development.

[34]  L. Pearl,et al.  Structure and mechanism of the Hsp90 molecular chaperone machinery. , 2006, Annual review of biochemistry.

[35]  Minoru Yoshida,et al.  HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. , 2005, Molecular cell.

[36]  L. Fritz,et al.  A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors , 2003, Nature.

[37]  R. Voellmy,et al.  Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) that Forms a Stress-Sensitive Complex with HSF1 , 1998, Cell.

[38]  S. Lindquist,et al.  Inhibiting the transcription factor HSF1 as an anticancer strategy. , 2009, Expert opinion on therapeutic targets.